Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Members of management and the Board of Directors have subscribed for units in Risk Intelligence A/S ongoing rights issue

Risk Intelligence A/S ("Risk Intelligence" or the "Company") can today announce that members of management and board of directors have subscribed for units in the ongoing rights issue of units of approx. DKK 2.1 million (the "Rights Issue") in accordance with the subscription commitments communicated in the memorandum, together with the additional subscriptions commitments that was communicated in the press release published on the 12 October 2023.The proceeds from the Rights Issue will be used to reestablish the equity, repay all short-term loans and for investments in new technology as

Scandinavian ChemoTech AB (publ) brings forward interim report

Scandinavian ChemoTech AB (publ) ("ChemoTech") has decided to bring forward the publication of the interim report for the third quarter to 17 October 2023.The interim report for the third quarter was previously scheduled for November 7, 2023, but is moved to October 17, 2023.   The reason for the change of date is that the completion of the interim report has been faster than expected, and that the Board of Directors believes that it is of value for shareholders and investors to be able to access as complete financial information as possible during the rights issue decided by the

Buybacks of shares in ITAB during week 41 2023

During the period between 9 and 13 October 2023, ITAB Shop Concept AB (publ) (”ITAB”) (LEI-code: 2138001H6FCSZBP26351) has repurchased in total 49,488 own ordinary shares (ISIN: SE0015962097) as part of the share buyback program initiated by the Board of Directors in order to optimise the capital structure.The share buybacks form part of the share buyback program in a maximum amount of MSEK 50 that ITAB announced on 28 September 2023. The share buyback program, which runs from 29 September 2023 until 14 May 2024, is being carried out in accordance with the EU Market Abuse Regulation (“MAR”)

Inhalation Sciences secures 188,900 Euro order from top-five global generics manufacturer

Inhalation Sciences AB (ISAB) has been awarded a new order from a returning customer for an Inhalation Research Services (IRS) project. The client has once again chosen DissolvIt, ISAB’s in vitro dissolution testing module, known for its precise prediction and comparison of how test generic formulations and originator products perform in the lung. DissolvIt provides a unique advantage for developers of complex generic inhaled therapies. DissolvIt testing is being adopted by a growing number of generic and novel biopharma companies.The returning client is amongst the world’s top five generic

Guelph General Hospital in Canada goes live with cloud-based enterprise imaging service from Sectra

Linköping, Sweden and Mississauga, ON – October 16, 2023 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) has successfully connected Guelph General Hospital to its cloud-based enterprise imaging SaaS, Sectra One Cloud. The service will further strengthen secure, efficient, and collaborative information sharing for the Canadian healthcare provider.As a pioneer to adopt Sectra One Cloud in Canada, Guelph General Hospital now utilizes the solution’s radiology, breast imaging, and orthopaedics modules, along with the vendor- neutral archive

Eevia Health Plc received a 541 kSEK / 47 kEUR sales order for a Bilberry extract product

Eevia Health Plc’s (”Eevia” or ”The Company”) has received a 47 kEUR (541 kSEK) repeat sales order from a German customer for Feno-Myrtillus 36 organic, an organically certified bilberry extract.Eevia received a new repeat order from a German customer for a bilberry extract. The German customer develops and markets vegan vitamins, superfoods, and sports nutrition under well-known brands. They use high quality raw materials in their own, innovative recipes.  The company maintains strict quality control and exclusively vegan products. The sales value to Eevia of this new order is c. kEUR

Nomination committee of OrganoClick AB for the AGM 2024

In accordance with the resolution at OrganoClick's Annual General Meeting (AGM) 2023, OrganoClick's nomination committee is composed of representatives of the three largest shareholders as of last August 2023. The nomination committee is composed of Peter Lindell, representing Cidro Förvaltning and himself, Håkan Gustavson representing Beijer Ventures, the Beijer foundations, and himself, and Mårten Hellberg, representing M. Hellberg AB and himself. Peter Lindell was appointed as Chairman of the Nomination committee as the individually largest shareholder in OrganoClick AB.The member of the

Press briefing 31 October: SEI experts present key topics ahead of COP28

On 31 October, Stockholm Environment Institute (SEI) invites you to a press briefing. Our leading experts will share their perspectives on the key issues set to dominate the upcoming 28[th] UN Climate Change Conference (COP28) in Dubai, United Arab Emirates. COP28 will take place from 30 November to 12 December 2023.Programme 14:00–14:05 Welcome and introductory remarksÅsa Persson, SEI Research Director and Deputy DirectorUlrika Lamberth, Senior Press Officer 14:05–15.00 Presentations · A big picture view of what we can expect from COP28Richard J.T Klein, Senior Research

Handelsbanken’s Interim Report for January – September 2023 will be presented Wednesday 18 October

Handelsbanken publishes its interim report for January ­– September 2023, at 07:00 a.m. CET Wednesday, 18 October. The report, slide presentation and Fact Book will be published on handelsbanken.com/ir. The President and Group Chief Executive Officer Carina Åkerström will present the interim report at 09:00 a.m. CET. The presentation will be broadcast live in Swedish and available at handelsbanken.com/ir and with the option for simultaneous interpretation into English. The presentation will be followed by a short break, after which a Q&A session will be held in English for analysts,

Esmaeilzadeh Holding publishes net asset value as of 30 September 2023

As of 30 September 2023, the net asset value for Esmaeilzadeh Holding AB (publ) was SEK 7.74 billion (SEK 7.78 billion as of 31 August 2023), corresponding to a net asset value per share of SEK 10,037 (SEK 10,093 as of 31 August 2023). For further information, please contact: Saeid Esmaeilzadeh, CEO and founder saeid@ehab.group Nils Fredrik Lagerstrand, General Counsel & Deputy CEO +46 720 90 26 99, nilsfredrik@ehab.group The information was submitted for publication, through the agency of the contact persons set out above, at 08.00 CEST on 16 October 2023. About

Introducing Advisense – uniting the strengths of FCG and Transcendent Group

Today, FCG and Transcendent Group are proud to announce the launch of our new, joint brand name – Advisense. In August 2022, FCG and Transcendent Group joined forces with the target to build a market leading governance, risk and compliance powerhouse in Europe and the best workplace for GRC experts. We are now proud to present the next step on our joint journey – introducing Advisense as our new corporate brand. “The name Advisense was designed to reflect the essence of what we bring to the market – advise and sensible solutions, helping our clients navigate a complex regulatory

New data from LEQEMBI® (lecanemab-irmb) phase 3 Clarity AD study and subcutaneous formulation to be presented at CTAD

Stockholm, October 16, 2023 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present new data from the phase 3 Clarity AD study for its Alzheimer’s disease (AD) treatment LEQEMBI® (lecanemab-irmb) 100 mg/mL injection for intravenous use, as well as new data on the subcutaneous formulation in development at the 16th annual Clinical Trials on Alzheimer’s Disease (CTAD) conference. The conference will be held in Boston, Massachusetts, United States and virtually from October 24 to 27, 2023. In addition, BioArctic will give an oral presentation on binding profiles of

Peab builds fire and emergency station in Norrköping

Peab has been commissioned to build a new fire and emergency station in Norrköping. The customer is Norrköping Municipality and the contract is worth EUR 132 million.The project comprises construction of a fire and emergency station with a garage and radio tower. The station will be built at Ljurafältet in Norrköping near to the E22 onramp. The main building will consist of offices, a garage, locker rooms, a gym, resting space, kitchen, dining room and a sauna.Peab will also build a supplementary building that will contain a garage and installations. Most of the frame will consist of

Invitation to conference call with web presentation of AcadeMedia's quarterly report for July - September 2023/24

AcadeMedia's quarterly report for July - September 2023/24 will be published at 08:00 CEST on 25 October. A web-cast telephone conference will be held at 09:30 CEST the same day, where CEO Marcus Strömberg, deputy CEO Katarina Wilson, and Hanna Clasén acting CFO will present the report. The presentation and following Q&A session will be held in English. To participate in the conference call please register via this link:https://conference.financialhearings.com/teleconference/?id=5001422 After registration, you will be provided with telephone numbers and a conference ID to access the

Announcement of a Change in Shareholding According to Chapter 9, Section 10 of the Finnish Securities Market Act

Sitowise Group Plc Stock Exchange Release 16 October 2023 at 9.00 a.m. (EEST) Sitowise Group Plc (the "Company") has on 13 October 2023 received a notification in accordance with the Chapter 9, Section 10 of the Finnish Securities Market Act from Morgan Stanley, according to which Morgan Stanley's holding of the shares and votes of the Company increased to 6.46 percent on 12 October 2023. According to the notification, Morgan Stanley holds indirectly a total of 2,121,999 shares corresponding to 5.95 percent of the Company’s shares and votes, and a total of 180,452 shares through

ICA Real Estate sells logistics property in Västerås to Genesta

ICA Real Estate has sold the logistics property Saltängen 1, ICA’s warehouse facility in Västerås, to Genesta through a so called sale and lease back transaction in which ICA Real Estate has signed a 15-year lease agreement with Genesta. The property area amounts to approximately 101,000 square metres.− We are happy about the transaction and the signing of a long-term lease agreement, and look forward to a good co-operation with Genesta. The deal frees up capital to reduce ICA Gruppen’s net debt, says Mattias Lundgren, acting CEO ICA Real Estate. −ICA Sweden logistics continues its

Kallelse till extra bolagsstämma i SpectrumOne AB (publ)

Aktieägarna i SpectrumOne AB (publ), org. nr 556526-6748 ("Bolaget") kallas härmed till extra bolagsstämma tisdagen den 31 oktober 2023 klockan 10:00 på Vasagatan 10, 4 tr i Stockholm. Rätt att delta på stämman Aktieägare som önskar delta vid stämman ska dels vara införd i den av Euroclear Sweden AB förda aktieboken per den 23 oktober 2023 och dels senast den 25 oktober 2023 anmäla sitt deltagande till Bolaget antingen per post till SpectrumOne AB, Att: Bolagsstämma, Kungsgatan 60, 111 22 Stockholm. Anmälan kan också göras per e-post till info@spectrumone.com. Vid anmälan skall

Additional data on BerGenBio’s selective AXL inhibitor bemcentinib to be presented at the 2023 ESMO meeting

BERGEN, Norway, October 16, 2023 – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, today announced that a poster and an oral presentation summarizing completed studies with its lead product candidate bemcentinib will be presented at the upcoming European Society of Clinical Oncologists (ESMO) Annual Meeting 2023, to be held October 20-24 in Madrid.   Enriqueta Felip, M.D., Ph.D., Head of the Thoracic Cancer Unit at Vall d’Hebron University Hospital, Spain will present the following

Aker Carbon Capture awarded pre-FEED in Sweden covering more than 200,000 tonnes of CO2 per year

Aker Carbon Capture has been awarded a pre-FEED (pre-Front End Engineering Design) for a Just Catch application by a Swedish energy company. The award follows an earlier feasibility study contract for another Swedish company, Söderenergi, announced in June, further strengthening Aker Carbon Capture’s position in the growing Swedish market.“We are pleased to see positive market development in Sweden. We have seen a significant boost in interest across the Scandinavian market after we won a contract in May to deliver five Just Catch units for Ørsted in Denmark. The level of activity has been

HYBRIT: Hydrogen storage reduces costs by up to 40 per cent

HYBRIT's hydrogen storage has now been tested commercially on the electricity market. Its excellent results are important for the industry's transition. Fossil-free hydrogen is a prerequisite for producing fossil-free steel. By also adding storage, the variable cost of hydrogen production can be significantly reduced, by between 25 to 40 per cent. HYBRIT is a collaboration between SSAB, LKAB and Vattenfall that started in 2016.The hydrogen storage facility was used specifically on the electricity market for about a month. The mission was to produce hydrogen using fossil-free electricity at

IRRAS has extended maturity date for its SEK 20 million short-term loan

2023-10-15 Stockholm, Sweden (October 15, 2023) – IRRAS AB (publ) (“IRRAS” or the “Company”) today announced an extension of its SEK 20 million short-term loan from IR Holding Bidco Inc. (“IR Holding”). The loan will continue to carry an interest rate in the amount of 6.00% on an annual basis. Under this extension, the loan will now fall due on 31 December 2023.  Repayment of the loan will continue to be secured by a pledge over the company’s patents and the shares of the company’s United States subsidiary, IRRAS USA Inc. In addition, IRRAS USA Inc. have guaranteed all obligations of

ChromoGenics will deliver Dynamic Glass to a project in Sweden

ChromoGenics will deliver ConverLight dynamic glass to a project in Sweden during the first half of 2024. Expected total order value is 5 MSEK. The product, ConverLight, is an advanced technology where an electrochromic film is laminated into the glass to regulate the intensity of sunlight and heat penetration into buildings. When the sun shines, the control system darkens the glass, significantly reducing the need for air conditioning. Similarly, solar heat can be allowed in during the winter to reduce energy consumption and heating costs. This solution also provides a natural daylight

Unique Home Storage Ideas By The Experts

Nobody likes clutter. However, clutter can very quickly build up in your home – especially when your home is on the smaller side. No matter how small your home may be, you should never allow it to hold you back from meeting all of your storage needs. Even the smallest of homes can incorporate some clever storage solutions to help keep all of the pesky clutter at bay.   [A white shelf with objects on it Description automatically generated]   Interior design expert Ryan McDonough at MyJobQuote.co.uk  has teamed up with a range of home improvement,

There are no items matching the current filter
There are no more items matching the current filter
Back to top